H.R.5041 - Safe Disposal of Unused Medication Act115th Congress (2017-2018)
|Sponsor:||Rep. Walberg, Tim [R-MI-7] (Introduced 02/15/2018)|
|Committees:||House - Energy and Commerce; Judiciary | Senate - Judiciary|
|Latest Action:||Senate - 06/13/2018 Received in the Senate and Read twice and referred to the Committee on the Judiciary. (All Actions)|
|Roll Call Votes:||There has been 1 roll call vote|
This bill has the status Passed House
Here are the steps for Status of Legislation:
- Passed House
Text: H.R.5041 — 115th Congress (2017-2018)All Information (Except Text)
Text available as:
Referred in Senate (06/13/2018)
Received; read twice and referred to the Committee on the Judiciary
To amend the Controlled Substances Act to authorize the employees of a hospice program to handle controlled substances lawfully in the possession of a deceased hospice patient for the purpose of disposal.
This Act may be cited as the “Safe Disposal of Unused Medication Act”.
Subsection (g) of section 302 of the Controlled Substances Act (21 U.S.C. 822) is amended by adding at the end the following:
“(5) (A) In the case of a person receiving hospice care, an employee of a qualified hospice program, acting within the scope of employment, may handle, without being registered under this section, any controlled substance that was lawfully dispensed to the person receiving hospice care, for the purpose of disposal of the controlled substance after the death of such person, so long as such disposal occurs onsite in accordance with all applicable Federal, State, Tribal, and local law.
“(i) The terms ‘hospice care’ and ‘hospice program’ have the meanings given to those terms in section 1861(dd) of the Social Security Act.
“(I) is employed by, or pursuant to arrangements made by, a qualified hospice program;
“(bb) is acting within the scope of such employment in accordance with applicable State law; and
“(III) has completed training through the qualified hospice program regarding the disposal of controlled substances in a secure and responsible manner so as to discourage abuse, misuse, or diversion.
“(I) has written policies and procedures for assisting in the disposal of the controlled substances of a person receiving hospice care after the person’s death;
“(aa) provides a copy of the written policies and procedures to the patient or patient representative and family;
“(bb) discusses the policies and procedures with the patient or representative and the family in a language and manner that they understand to ensure that these parties are educated regarding the safe disposal of controlled substances; and
“(cc) documents in the patient’s clinical record that the written policies and procedures were provided and discussed; and
“(aa) documents in the patient’s clinical record the type of controlled substance, dosage, route of administration, and quantity so disposed; and
“(bb) the time, date, and manner in which that disposal occurred.”.
Passed the House of Representatives June 12, 2018.
|Attest:||karen l. haas,|